BACKGROUND: Exposure to traffic-related air pollutants, including polycyclic aromatic hydrocarbons (PAHs), can induce asthma. However, the effects of early repeated PAH exposure over time on different asthma phenotypes have not been examined. OBJECTIVE: To assess associations between repeated PAH exposure, measured from prenatal personal and residential indoor monitors in children's homes, and asthma in an inner-city cohort. METHODS: Prenatal exposure was assessed by personal air monitoring during 48 hours and exposure at 5 to 6 years of age by 2-week residential monitoring in the Columbia Center for Children's Environmental Health cohort. PAH was dichotomized into pyrene (representative semivolatile PAH) and the sum of 8 nonvolatile PAHs. High exposure to each was defined as measures above the median at both repeated time points. Asthma and wheeze were determined by validated questionnaires at ages 5 to 6 years. Children with specific IgE levels greater than 0.35 IU/mL to any of 5 indoor allergens were considered seroatopic. RESULTS: Among all 354 children, repeated high exposure to pyrene was associated with asthma (odds ratio [OR], 1.90; 95% confidence interval [CI], 1.13-3.20). Among 242 nonatopic children, but not those sensitized to indoor allergens (n = 87) or with elevated total IgE levels (n = 171), high pyrene levels were associated positively with asthma (OR, 2.89; 95% CI, 1.77-5.69), asthma medication use (OR, 2.28; 95% CI, 1.13-4.59), and emergency department visits for asthma (OR, 2.43; 95% CI, 1.20-4.91). Associations between the levels of the 8 nonvolatile PAHs and asthma were not observed, even when stratifying by seroatopy. CONCLUSION: Nonatopic children may be more susceptible to the respiratory consequences of early pyrene exposures.
BACKGROUND: Exposure to traffic-related air pollutants, including polycyclic aromatic hydrocarbons (PAHs), can induce asthma. However, the effects of early repeated PAH exposure over time on different asthma phenotypes have not been examined. OBJECTIVE: To assess associations between repeated PAH exposure, measured from prenatal personal and residential indoor monitors in children's homes, and asthma in an inner-city cohort. METHODS: Prenatal exposure was assessed by personal air monitoring during 48 hours and exposure at 5 to 6 years of age by 2-week residential monitoring in the Columbia Center for Children's Environmental Health cohort. PAH was dichotomized into pyrene (representative semivolatile PAH) and the sum of 8 nonvolatile PAHs. High exposure to each was defined as measures above the median at both repeated time points. Asthma and wheeze were determined by validated questionnaires at ages 5 to 6 years. Children with specific IgE levels greater than 0.35 IU/mL to any of 5 indoor allergens were considered seroatopic. RESULTS: Among all 354 children, repeated high exposure to pyrene was associated with asthma (odds ratio [OR], 1.90; 95% confidence interval [CI], 1.13-3.20). Among 242 nonatopic children, but not those sensitized to indoor allergens (n = 87) or with elevated total IgE levels (n = 171), high pyrene levels were associated positively with asthma (OR, 2.89; 95% CI, 1.77-5.69), asthma medication use (OR, 2.28; 95% CI, 1.13-4.59), and emergency department visits for asthma (OR, 2.43; 95% CI, 1.20-4.91). Associations between the levels of the 8 nonvolatile PAHs and asthma were not observed, even when stratifying by seroatopy. CONCLUSION: Nonatopic children may be more susceptible to the respiratory consequences of early pyrene exposures.
Authors: M A Jenkins; J R Clarke; J B Carlin; C F Robertson; J L Hopper; M F Dalton; D P Holst; K Choi; G G Giles Journal: Int J Epidemiol Date: 1996-06 Impact factor: 7.196
Authors: Thais Mauad; Dolores Helena Rodriguez Ferreira Rivero; Regiani Carvalho de Oliveira; Ana Julia de Faria Coimbra Lichtenfels; Eliane Tigre Guimarães; Paulo Afonso de Andre; David Itiro Kasahara; Heloisa Maria de Siqueira Bueno; Paulo Hilário Nascimento Saldiva Journal: Am J Respir Crit Care Med Date: 2008-07-02 Impact factor: 21.405
Authors: Mauricio L Barreto; Sergio S Cunha; Rosemeire Fiaccone; Renata Esquivel; Leila D Amorim; Sheila Alvim; Matildes Prado; Alvaro A Cruz; Philip J Cooper; Darci N Santos; Agostino Strina; Neuza Alcantara-Neves; Laura C Rodrigues Journal: Respir Res Date: 2010-12-01
Authors: Kyung Hwa Jung; Matthew Perzanowski; Andrew Rundle; Kathleen Moors; Beizhan Yan; Steven N Chillrud; Robin Whyatt; David Camann; Frederica P Perera; Rachel L Miller Journal: Environ Res Date: 2013-12-27 Impact factor: 6.498
Authors: Kelly J Brunst; Patrick H Ryan; Cole Brokamp; David Bernstein; Tiina Reponen; James Lockey; Gurjit K Khurana Hershey; Linda Levin; Sergey A Grinshpun; Grace LeMasters Journal: Am J Respir Crit Care Med Date: 2015-08-15 Impact factor: 21.405
Authors: Wiesław A Jedrychowski; Frederica P Perera; Renata Majewska; David Camman; John D Spengler; Elzbieta Mroz; Laura Stigter; Elżbieta Flak; Ryszard Jacek Journal: Pediatr Pulmonol Date: 2013-10-24
Authors: Allan C Just; Rachel L Miller; Matthew S Perzanowski; Andrew G Rundle; Qixuan Chen; Kyung Hwa Jung; Lori Hoepner; David E Camann; Antonia M Calafat; Frederica P Perera; Robin M Whyatt Journal: J Expo Sci Environ Epidemiol Date: 2015-02-18 Impact factor: 5.563
Authors: Stephanie Lovinsky-Desir; Kyung Hwa Jung; Andrew G Rundle; Lori A Hoepner; Joshua B Bautista; Frederica P Perera; Steven N Chillrud; Matthew S Perzanowski; Rachel L Miller Journal: Environ Res Date: 2016-09-29 Impact factor: 6.498
Authors: Matthew S Perzanowski; Ginger L Chew; Adnan Divjan; Kyung Hwa Jung; Robert Ridder; Deliang Tang; Diurka Diaz; Inge F Goldstein; Patrick L Kinney; Andrew G Rundle; David E Camann; Frederica P Perera; Rachel L Miller Journal: J Allergy Clin Immunol Date: 2013-02-04 Impact factor: 10.793
Authors: Wieslaw A Jedrychowski; Frederica P Perera; Umberto Maugeri; Renata Majewska; Elzbieta Mroz; Elzbieta Flak; David Camann; Agata Sowa; Ryszard Jacek Journal: Sci Total Environ Date: 2014-10-06 Impact factor: 7.963